IGF-1 LR3 Product Information
Receptor Grade IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a synthetic peptide research compound evaluated exclusively in laboratory and preclinical research settings. It is a structurally modified analog of native IGF-1, incorporating an amino-acid substitution at position 3 and an extended amino-acid sequence at the N-terminus. These modifications are examined in research environments for their influence on molecular stability, receptor interaction characteristics, and experimental handling behavior under controlled conditions. In non-human laboratory models and in vitro systems, IGF-1 LR3 is utilized to study insulin-like growth factor receptor (IGF-1R) binding dynamics, downstream signaling pathway activation patterns, and peptide–receptor interaction behavior. Research involving this compound focuses on characterizing growth factor–associated signaling cascades, cellular signaling coordination, and molecular response mechanisms without implying functional enhancement, tissue repair, or physiological outcomes. Additional investigations reference IGF-1 LR3 for comparative analysis of receptor affinity, signaling duration, and interaction behavior relative to unmodified IGF-1 in controlled experimental systems. Its reduced interaction with IGF binding proteins is examined in research contexts to better understand peptide availability, receptor engagement, and signaling behavior during laboratory experimentation. This material is supplied exclusively for laboratory research and analytical use by qualified professionals. It is not intended for human use, animal use, diagnostic purposes, or therapeutic application. Summary of Characteristics Characteristic Details Chemical Sequence of Amino Acids MFPAMPLSSL FVNGPRTLCG AELVDALQFV CGDRGFYFNK PTGYGSSSRR APQTGIVDEC CFRSCDLRRL EMYCAPLKPA KSA CAS Number 143045-27-6 Molecular Formula C400H625N111O115S9 Molecular Weight 9,117.60 g/mol Other Known Titles IGF-1 LR3 research peptide; Long R3 IGF-1; insulin-like growth factor-1 Long R3
